Filing metadata

Accession number
0001169245-20-000027
Form type
Form 4
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
Feb 14, 2020
Reporting period
Feb 12, 2020
Description
Insider transaction

Explore SEC Filings Hub